NATURECELL CO.,LTD.

007390 KRX Pharmaceuticals Pharmaceuticals
KOSDAQ

Shareholding pattern

As reported to FSS/DART, 2025-12-31.

Largest shareholder group17.83%
Minority shareholders81.76%
Top 10 holders17.83%
Total shareholders61,971

Who owns the company

Share of shares outstanding
Minority shareholders: 81.76%Largest shareholder & related parties: 17.83%81.8%Minority shareholders
Minority shareholders 81.76%Largest shareholder & related parties 17.83%

How to read this: the largest shareholder group is the controlling owner and related parties — a big slice means tight control. Minority shareholders are the many small holders. The remainder is mostly institutional and foreign money, which the regulator does not itemise separately.

Ownership detail

Investor categoryHolding %Shareholders
Minority shareholders81.76%61,906
Largest shareholder & related parties17.83%

How to read this: a high foreign or institutional share often means the stock is widely researched and more liquid; a high individual share means retail investors hold most of the company. Percentages are of voting units.

Largest shareholders

S.No.ShareholderSharesStake %
1(주)바이오스타줄기세포기술연구원5,953,9699.24%
2(주)알바이오4,305,0776.68%
3라정찬865,4001.34%
4권순미123,4690.19%
5라기원103,4100.16%
6(주)JASC74,4980.11%
7라기혜66,4440.10%
8박상철4,8710.01%
9변대중0.00%

Trust banks such as Master Trust and Custody Bank appear at the top of most Japanese registers: they hold shares on behalf of many underlying funds rather than owning them outright.

Educational data only. Not a recommendation to buy, sell or hold any security.